Moderna, Inc. (MRNA) Valuation: Intrinsic & Fair Value
Moderna, Inc. (MRNA) intrinsic value, fair value and valuation analysis based on SEC filings. Over the last 5 years its EPS -28.9% and free cash flow/share -64.4% compounded annually (from SEC filings). See whether MRNA looks undervalued or overvalued using P/E, FCF, OCF and DCF models with 5-year projections — Biological Products, (No Diagnostic Substances).
Wondering what Moderna, Inc. is worth? Estimate MRNA's intrinsic value and fair value from its SEC-reported earnings and cash flow, and see whether MRNA stock looks undervalued or overvalued today — using P/E, DCF, free cash flow and operating cash flow models with 5-year projections.
Related stocks
LOCKHEED MARTIN CORP (LMT) · FORD MOTOR CO (F) · Rivian Automotive, Inc. / DE (RIVN) · Lucid Group, Inc. (LCID) · Carnival Corp Ltd. (CCL) · United Airlines Holdings, Inc. (UAL) · Riot Platforms, Inc. (RIOT) · ROKU, INC (ROKU)
How to run this valuation
How to value a stock · The P/E ratio explained · DCF analysis explained · Free cash flow vs. operating cash flow · Which valuation method to use · Is a stock over- or undervalued?
Frequently asked questions about Moderna, Inc. valuation
Is Moderna, Inc. (MRNA) stock overvalued or undervalued?
To tell whether MRNA is overvalued or undervalued, compare its current share price to an intrinsic value estimate. This page runs P/E, discounted cash flow (DCF), free cash flow and operating cash flow models on Moderna, Inc.'s SEC-reported fundamentals so you can see a fair value range and how much upside or downside the current price implies.
What is Moderna, Inc.'s fair value?
Fair value is the price justified by Moderna, Inc.'s earnings and cash flows rather than its market quote. It depends on the growth rate and exit multiple you assume, so MRNA's valuation here is shown as a bear, base and bull range — letting you see the assumptions under which MRNA looks cheap or expensive.
How do you calculate Moderna, Inc.'s intrinsic value?
Project Moderna, Inc.'s future earnings or cash flow, then either apply a P/E multiple or discount the cash flows back to today with a DCF. This tool automates both on MRNA's SEC data and adds a 5-year sensitivity matrix, so small changes in growth or discount rate are easy to see.
What is Moderna, Inc. (MRNA) worth?
Moderna, Inc.'s worth is the present value of the cash it will generate for shareholders. Rather than quoting a single number, this page lets you estimate MRNA's worth yourself from its SEC filings across four models, so the answer reflects your own growth and discount-rate assumptions.